Audited Financial Results of the Company (Standalone & Consolidated) for the Fourth Quarter and Financial Year ended on 31st March, 2026.

Gujarat Alkalies reported standalone revenue of Rs. 4,35,808 Lakhs, up 7% YoY, with PAT growing 31.7% to Rs. 2,084 Lakhs from Rs. 1,582 Lakhs. Consolidated results reflect a JV loss of Rs. 2,325 Lakhs, resulting in a consolidated net loss of Rs. 241 Lakhs vs a loss of Rs. 6,512 Lakhs in the prior year — a major turnaround. Revenue growth was modest at ~7%, not meeting a high-growth threshold. The company recommended a dividend of Rs. 17.70 per share (177%). Auditors issued unmodified opinions with an Emphasis of Matter on the MCA-sanctioned Composite Scheme of Amalgamation and Arrangement. The JV (GACL-NALCO) incurred losses of Rs. 3,868.72 Lakhs with accumulated losses of Rs. 63,330.82 Lakhs; an external expert confirmed no impairment is required on the Rs. 41,400 Lakhs JV investment. The Board approved a new 5000 TPA High Purity Grade Hydrogen Peroxide plant at Dahej at Rs. 67 Crores, expected to generate Rs. 42 Crores in annual revenue.